Microneedle

Microneedle designates miniature needle structures, typically ranging from tens to hundreds of micrometres in length, designed to penetrate the stratum corneum reaching viable epidermis or upper dermis while avoiding dermal nerve endings and blood vessels, enabling minimally invasive transdermal drug delivery, biosensing, or fluid sampling. These devices overcome stratum corneum barrier properties limiting conventional transdermal delivery to small lipophilic molecules by creating temporary microscopic transport pathways.

The biopharmaceutical industry develops microneedle-based delivery systems offering improved patient compliance through painless administration, enhanced vaccine immunogenicity through targeting skin immune cells, and temperature-stable formulations potentially eliminating cold chain requirements. Microneedle designs span solid, coated, dissolving, hollow, and hydrogel-forming formats, each with distinct delivery mechanisms and applications. Vaccine delivery represents a prominent application, with microneedle patches demonstrating immunogenicity comparable to intramuscular injections while offering thermostability and simpler administration. Protein therapeutics including insulin and monoclonal antibodies delivered via microneedles provide alternatives to subcutaneous injections with improved patient acceptance. Diagnostic applications include microneedle-based biosensors for continuous glucose monitoring or interstitial fluid biomarker analysis. As clinical evidence demonstrates efficacy and manufacturing capabilities advance, microneedle technology continues advancing as a versatile platform for transdermal delivery.